{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:41:36Z","timestamp":1792442496704,"version":"4.5.0"},"reference-count":96,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CRP"],"published-print":{"date-parts":[[2020,3,13]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cutaneous malignant melanoma is a neoplasm whose incidence and mortality\nare dramatically increasing. 18F-FDG PET\/CT gained clinical acceptance over the past 2 decades in the\nevaluation of several glucose-avid neoplasms, including malignant melanoma, particularly for the assessment\nfor distant metastases, recurrence and response to therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>To describe the advancements of nuclear medicine for imaging melanoma with particular\nattention to 18F-FDG-PET and its current state-of-the-art technical innovations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p> A comprehensive search strategy was used based on SCOPUS and PubMed databases. From\nall studies published in English, we selected the articles that evaluated the technological insights of 18FFDG-\nPET in the assessment of melanoma.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>State-of-the-art silicon photomultipliers based detectors (\u201cdigital\u201d) PET\/CT scanners are\nnowadays more common, showing technical innovations that may have beneficial implications for\npatients with melanoma. Steady improvements in detectors design and architecture, as well as the implementation\nof both software and hardware technology (i.e., TOF, point spread function, etc.), resulted\nin significant improvements in PET image quality while reducing radiotracer dose and scanning time.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Recently introduced digital PET detector technology in PET\/CT and PET\/MRI yields\nhigher intrinsic system sensitivity compared with the latest generation analog technology, enabling the\ndetection of very small lesions with potential impact on disease outcome.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1874471012666191015095550","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T14:44:12Z","timestamp":1571409852000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Malignant Cutaneous Melanoma: Updates in PET Imaging"],"prefix":"10.2174","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2842-0301","authenticated-orcid":true,"given":"Riccardo","family":"Laudicella","sequence":"first","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina ME, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Baratto","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Minutoli","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina ME, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Baldari","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, Nuclear Medicine Unit, University of Messina, Messina ME, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Iagaru","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.det.2012.04.001","volume":"30","author":"Little E.G.","year":"2012","unstructured":"Little E.G.; Eide M.J.; Update on the current state of melanoma incidence. Dermatol Clin 2012,30(3),355-361","journal-title":"Dermatol Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"Siegel R.L.","year":"2018","unstructured":"Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2018. CA Cancer J Clin 2018,68(1),7-30","journal-title":"CA Cancer J Clin"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"Gershenwald J.E.","year":"2017","unstructured":"Gershenwald J.E.; Scolyer R.A.; Hess K.R.; Sondak V.K.; Long G.V.; Ross M.I.; Lazar A.J.; Faries M.B.; Kirkwood J.M.; McArthur G.A.; Haydu L.E.; Eggermont A.M.M.; Flaherty K.T.; Balch C.M.; Thompson J.F.; Melanoma staging: Evidence-based\nchanges in the American Joint Committee on Cancer eighth edition\ncancer staging manual CA Cancer J Clin;, 2017,67(6),472-492","journal-title":"CA Cancer J Clin;,"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"vi14","DOI":"10.1093\/annonc\/mdp256","volume":"20","author":"Mohr P.","year":"2009","unstructured":"Mohr P.; Eggermont A.M.; Hauschild A.; Buzaid A.; Staging of cutaneous melanoma. Ann Oncol 2009,20(Suppl. 6),vi14-vi21","journal-title":"Ann Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","volume":"65","author":"Bichakjian C.K.","year":"2011","unstructured":"Bichakjian C.K.; Halpern A.C.; Johnson T.M.; Foote Hood A.; Grichnik J.M.; Swetter S.M.; Tsao H.; Barbosa V.H.; Chuang T.Y.; Duvic M.; Ho V.C.; Sober A.J.; Beutner K.R.; Bhushan R.; Smith Begolka W.; American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2011,65(5),1032-1047","journal-title":"J Am Acad Dermatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","volume":"20","author":"Dickson P.V.","year":"2011","unstructured":"Dickson P.V.; Gershenwald J.E.; Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am 2011,20(1),1-17","journal-title":"Surg Oncol Clin N Am"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.rcl.2013.06.004","volume":"51","author":"Bourgeois A.C.","year":"2013","unstructured":"Bourgeois A.C.; Chang T.T.; Fish L.M.; Bradley Y.C.; Positron emission tomography\/computed tomography in melanoma. Radiol Clin North Am 2013,51(5),865-879","journal-title":"Radiol Clin North Am"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa050092","volume":"353","author":"Curtin J.A.","year":"2005","unstructured":"Curtin J.A.; Fridlyand J.; Kageshita T.; Patel H.N.; Busam K.J.; Kutzner H.; Cho K.H.; Aiba S.; Br\u00f6cker E.B.; LeBoit P.E.; Pinkel D.; Bastian B.C.; Distinct sets of genetic alterations in melanoma. N Engl J Med 2005,353(20),2135-2147","journal-title":"N Engl J Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"Curtin J.A.","year":"2006","unstructured":"Curtin J.A.; Busam K.; Pinkel D.; Bastian B.C.; Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006,24(26),4340-4346","journal-title":"J Clin Oncol"},{"key":"ref=10","unstructured":"Melanoma, version 1.2018. In:NCCN clinical practice guidelines in oncology. Fort Washington, PA: National Comprehensive Cancer Network, 2017. Available from:."},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-3-642-05072-5","author":"Dummer R.","year":"2011","unstructured":"Dummer R.; Pittelkow M.R.; Iwatsuki K.; Green A.; Elwan N.M.;  Skin cancer: a world-wide perspective 2011,307-342","journal-title":"Skin cancer: a world-wide perspective"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.clindermatol.2012.08.004","volume":"31","author":"Ross M.I.","year":"2013","unstructured":"Ross M.I.; Gershenwald J.E.; Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience. Clin Dermatol 2013,31(3),298-310","journal-title":"Clin Dermatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","volume":"17","author":"Gershenwald J.E.","year":"1999","unstructured":"Gershenwald J.E.; Thompson W.; Mansfield P.F.; Lee J.E.; Colome M.I.; Tseng C.H.; Lee J.J.; Balch C.M.; Reintgen D.S.; Ross M.I.; Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999,17(3),976-983","journal-title":"J Clin Oncol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.2967\/jnumed.114.153643","volume":"56","author":"Jimenez-Heffernan A.","year":"2015","unstructured":"Jimenez-Heffernan A.; Ellmann A.; Sado H.; Hui\u0107 D.; Bal C.; Parameswaran R.; Giammarile F.; Pruzzo R.; Kostadinova I.; Vorster M.; Almeida P.; Santiago J.; Gambhir S.; Sergieva S.; Calderon A.; Young G.O.; Valdes-Olmos R.; Zaknun J.; Magboo V.P.; Pascual T.N.; Results of a Prospective Multicenter International Atomic Energy Agency Sentinel Node Trial on the Value of SPECT\/CT Over Planar Imaging in Various Malignancies. J Nucl Med 2015,56(9),1338-1344","journal-title":"J Nucl Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-2133.2002.04867.x","volume":"147","author":"Meier F.","year":"2002","unstructured":"Meier F.; Will S.; Ellwanger U.; Schlagenhauff B.; Schittek B.; Rassner G.; Garbe C.; Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002,147(1),62-70","journal-title":"Br J Dermatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"Balch C.M.","year":"2001","unstructured":"Balch C.M.; Soong S.J.; Gershenwald J.E.; Thompson J.F.; Reintgen D.S.; Cascinelli N.; Urist M.; McMasters K.M.; Ross M.I.; Kirkwood J.M.; Atkins M.B.; Thompson J.A.; Coit D.G.; Byrd D.; Desmond R.; Zhang Y.; Liu P.Y.; Lyman G.H.; Morabito A.; Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001,19(16),3622-3634","journal-title":"J Clin Oncol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/jso.20079","volume":"86","author":"Leiter U.","year":"2004","unstructured":"Leiter U.; Meier F.; Schittek B.; Garbe C.; The natural course of cutaneous melanoma. J Surg Oncol 2004,86(4),172-178","journal-title":"J Surg Oncol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/BF02303765","volume":"5","author":"Mooney M.M.","year":"1998","unstructured":"Mooney M.M.; Kulas M.; McKinley B.; Michalek A.M.; Kraybill W.G.; Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma. Ann Surg Oncol 1998,5(1),54-63","journal-title":"Ann Surg Oncol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","volume":"66","author":"Kim J.W.","year":"2006","unstructured":"Kim J.W.; Dang C.V.; Cancer\u2019s molecular sweet tooth and the Warburg effect. Cancer Res 2006,66(18),8927-8930","journal-title":"Cancer Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/snuc.2002.29269","volume":"32","author":"Alavi A.","year":"2002","unstructured":"Alavi A.; Reivich M.; Guest editorial: the conception of FDG-PET imaging. Semin Nucl Med 2002,32(1),2-5","journal-title":"Semin Nucl Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejim.2013.06.012","volume":"25","author":"Tagliabue L.","year":"2014","unstructured":"Tagliabue L.; Del Sole A.; Appropriate use of positron emission tomography with [(18)F]fluorodeoxyglucose for staging of oncology patients. Eur J Intern Med 2014,25(1),6-11","journal-title":"Eur J Intern Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1158\/1078-0432.CCR-04-2626","volume":"11","author":"Kelloff G.J.","year":"2005","unstructured":"Kelloff G.J.; Hoffman J.M.; Johnson B.; Scher H.I.; Siegel B.A.; Cheng E.Y.; Cheson B.D.; O\u2019shaughnessy J.; Guyton K.Z.; Mankoff D.A.; Shankar L.; Larson S.M.; Sigman C.C.; Schilsky R.L.; Sullivan D.C.; Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development. Clin Cancer Res 2005,11(8),2785-2808","journal-title":"Clin Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"MMT06","DOI":"10.2217\/mmt-2017-0022","volume":"5","author":"Perissinotti A.","year":"2018","unstructured":"Perissinotti A.; Rietbergen D.D.; Vidal-Sicart S.; Riera A.A.; Olmos R.A.V.; Melanoma","journal-title":"Melanoma Manag"},{"key":"ref=24","first-page":"957","volume":"47","author":"Belhocine T.Z.","year":"2006","unstructured":"Belhocine T.Z.; Scott A.M.; Even-Sapir E.; Urbain J.L.; Essner R.; Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006,47(6),957-967","journal-title":"J Nucl Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00259-015-3217-0","volume":"43","author":"Petersen H.","year":"2016","unstructured":"Petersen H.; Holdgaard P.C.; Madsen P.H.; Knudsen L.M.; Gad D.; Gravergaard A.E.; Rohde M.; Godballe C.; Engelmann B.E.; Bech K.; Teilmann-J\u00f8rgensen D.; Mogensen O.; Karstoft J.; Johansen J.; Christensen J.B.; Johansen A.; H\u00f8ilund-Carlsen P.F.; PET\/CT Task Force of the Region of Southern Denmark. FDG PET\/CT in cancer: comparison of actual use with literature-based recommendations. Eur J Nucl Med Mol Imaging 2016,43(4),695-706","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"Balch C.M.","year":"2009","unstructured":"Balch C.M.; Gershenwald J.E.; Soong S.J.; Thompson J.F.; Atkins M.B.; Byrd D.R.; Buzaid A.C.; Cochran A.J.; Coit D.G.; Ding S.; Eggermont A.M.; Flaherty K.T.; Gimotty P.A.; Kirkwood J.M.; McMasters K.M.; Mihm M.C.; Morton D.L.; Ross M.I.; Sober A.J.; Sondak V.K.; Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009,27(36),6199-6206","journal-title":"J Clin Oncol"},{"key":"ref=27","first-page":"1126","volume":"172","author":"Horn J.","year":"2010","unstructured":"Horn J.; Sj\u00f8strand H.; Lock-Andersen J.; Loft A.; [PET scanning for malignant melanoma and positive sentinel node diagnostics]. Ugeskr Laeger 2010,172(15),1126-1130","journal-title":"Ugeskr Laeger"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1245\/s10434-010-1088-y","volume":"17","author":"Aukema T.S.","year":"2010","unstructured":"Aukema T.S.; Vald\u00e9s Olmos R.A.; Wouters M.W.; Klop W.M.; Kroon B.B.; Vogel W.V.; Nieweg O.E.; Utility of preoperative 18F-FDG PET\/CT and brain MRI in melanoma patients with palpable lymph node metastases. Ann Surg Oncol 2010,17(10),2773-2778","journal-title":"Ann Surg Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4774","DOI":"10.1200\/JCO.2008.20.1822","volume":"27","author":"Bastiaannet E.","year":"2009","unstructured":"Bastiaannet E.; Wobbes T.; Hoekstra O.S.; van der Jagt E.J.; Brouwers A.H.; Koelemij R.; de Klerk J.M.; Oyen W.J.; Meijer S.; Hoekstra H.J.; Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. J Clin Oncol 2009,27(28),4774-4780","journal-title":"J Clin Oncol"},{"key":"ref=30","first-page":"1323","volume":"45","author":"Fuster D.","year":"2004","unstructured":"Fuster D.; Chiang S.; Johnson G.; Schuchter L.M.; Zhuang H.; Alavi A.; Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J Nucl Med 2004,45(8),1323-1327","journal-title":"J Nucl Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3413\/Nukmed-0584-13-05","volume":"52","author":"Wieder H.A.","year":"2013","unstructured":"Wieder H.A.; Tekin G.; Rosenbaum-Krumme S.; Klode J.; Altenbernd J.; Bockisch A.; Nagarajah J.; 18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma. Nucl Med (Stuttg) 2013,52(5),198-203","journal-title":"Nucl Med (Stuttg)"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.03.5634","volume":"24","author":"Reinhardt M.J.","year":"2006","unstructured":"Reinhardt M.J.; Joe A.Y.; Jaeger U.; Huber A.; Matthies A.; Bucerius J.; Roedel R.; Strunk H.; Bieber T.; Biersack H.J.; T\u00fcting T.; Diagnostic performance of whole body dual modality\n18F-FDG PET\/CT imaging for N- and M-staging of malignant\nmelanoma: experience with 250 consecutive patients J Clin Oncol, 2006,24(7),1178-87.0","journal-title":"J Clin Oncol,"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"Wahl R.L.","year":"2009","unstructured":"Wahl R.L.; Jacene H.; Kasamon Y.; Lodge M.A.; From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors. J Nucl Med 2009,50(Suppl. 1),122S-150S","journal-title":"J Nucl Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1102\/1470-7330.2005.0006","volume":"5","author":"Hicks R.J.","year":"2005","unstructured":"Hicks R.J.; The role of PET in monitoring therapy. Cancer Imaging 2005,5,51-57","journal-title":"Cancer Imaging"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/MNM.0b013e3282f1b97b","volume":"28","author":"Hofman M.S.","year":"2007","unstructured":"Hofman M.S.; Constantinidou A.; Acland K.; Healy C.; Harries M.; O\u2019Doherty M.; Melanoma Group.Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience. Nucl Med Commun 2007,28(12),902-906","journal-title":"Nucl Med Commun"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s00259-008-0806-1","volume":"35","author":"Strobel K.","year":"2008","unstructured":"Strobel K.; Dummer R.; Steinert H.C.; Conzett K.B.; Schad K.; Lago M.P.; Soyka J.D.; Veit-Haibach P.; Seifert B.; Kalff V.; Chemotherapy response assessment in stage IV melanoma patients-comparison of 18F-FDG-PET\/CT, CT, brain MRI, and tumormarker S-100B. Eur J Nucl Med Mol Imaging 2008,35(10),1786-1795","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/SLA.0b013e318256d1f5","volume":"256","author":"Beasley G.M.","year":"2012","unstructured":"Beasley G.M.; Parsons C.; Broadwater G.; Selim M.A.; Marzban S.; Abernethy A.P.; Salama A.K.; Eikman E.A.; Wong T.; Zager J.S.; Tyler D.S.; A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET\/CT in patients with AJCC stage IIIB or IIIC extremity melanoma. Ann Surg 2012,256(2),350-356","journal-title":"Ann Surg"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.2967\/jnumed.112.109421","volume":"53","author":"Kraeber-Bod\u00e9r\u00e9 F.","year":"2012","unstructured":"Kraeber-Bod\u00e9r\u00e9 F.; Carlier T.; Naegelen V.M.; Shochat E.; Lumbroso J.; Trampal C.; Nagarajah J.; Chua S.; Hugonnet F.; Stokkel M.; Gleeson F.; Tessier J.; Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials. J Nucl Med 2012,53(12),1836-1846","journal-title":"J Nucl Med"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-017-3691-7","volume":"44","author":"Wong A.N.M.","year":"2017","unstructured":"Wong A.N.M.; McArthur G.A.; Hofman M.S.; Hicks R.J.; The Advantages and Challenges of Using FDG PET\/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy. Eur J Nucl Med Mol Imaging 2017,44(Suppl. 1),67-77","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1148\/radiol.2382041977","volume":"238","author":"von Schulthess G.K.","year":"2006","unstructured":"von Schulthess G.K.; Steinert H.C.; Hany T.F.; Integrated PET\/CT: current applications and future directions. Radiology 2006,238(2),405-422","journal-title":"Radiology"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0001-7310(07)70128-X","volume":"98","author":"Tejera-Vaquerizo A.","year":"2007","unstructured":"Tejera-Vaquerizo A.; Barrera-Vigo M.V.; Fern\u00e1ndez-Canedo I.; Bl\u00e1zquez-S\u00e1nchez N.; Mendiola-Fern\u00e1ndez M.; Fern\u00e1ndez-Orland A.; Bosch-Garc\u00eda R.; de Troya-Mart\u00edn M.; Herrera-Ceballos E.; [Longitudinal study of different metastatic patterns in the progression of cutaneous melanoma]. Actas Dermosifiliogr 2007,98(8),531-538","journal-title":"Actas Dermosifiliogr"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.adengl.2012.12.006","volume":"104","author":"Marcoval J.","year":"2013","unstructured":"Marcoval J.; Ferreres J.R.; Mart\u00edn C.; G\u00f3mez S.; Pen\u00edn R.M.; Ochoa de Olza M.; Fabra \u00c1.; Patterns of visceral metastasis in cutaneous melanoma: a descriptive study. Actas Dermosifiliogr 2013,104(7),593-597","journal-title":"Actas Dermosifiliogr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1002\/cncr.10541","volume":"94","author":"Schouten L.J.","year":"2002","unstructured":"Schouten L.J.; Rutten J.; Huveneers H.A.; Twijnstra A.; Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002,94(10),2698-2705","journal-title":"Cancer"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","volume":"22","author":"Barnholtz-Sloan J.S.","year":"2004","unstructured":"Barnholtz-Sloan J.S.; Sloan A.E.; Davis F.G.; Vigneau F.D.; Lai P.; Sawaya R.E.; Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004,22(14),2865-2872","journal-title":"J Clin Oncol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","volume":"75","author":"Gavrilovic I.T.","year":"2005","unstructured":"Gavrilovic I.T.; Posner J.B.; Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005,75(1),5-14","journal-title":"J Neurooncol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/0284185113476021","volume":"54","author":"Sebro R.","year":"2013","unstructured":"Sebro R.; Mari-Aparici C.; Hernandez-Pampaloni M.; Value of true whole-body FDG-PET\/CT scanning protocol in oncology: optimization of its use based on primary diagnosis. Acta Radiol 2013,54(5),534-539","journal-title":"Acta Radiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s12149-014-0814-0","volume":"28","author":"Kawata S.","year":"2014","unstructured":"Kawata S.; Imaizumi M.; Kako Y.; Oku N.; Clinical impact of \u201ctrue whole-body\u201d (18)F-FDG PET\/CT: lesion frequency and added benefit in distal lower extremities. Ann Nucl Med 2014,28(4),322-328","journal-title":"Ann Nucl Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2342-7-8","volume":"7","author":"Nguyen N.C.","year":"2007","unstructured":"Nguyen N.C.; Chaar B.T.; Osman M.M.; Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET\/CT. BMC Med Imaging 2007,7,8","journal-title":"BMC Med Imaging"},{"key":"ref=49","first-page":"752","volume":"46","author":"Ishimori T.","year":"2005","unstructured":"Ishimori T.; Patel P.V.; Wahl R.L.; Detection of unexpected additional primary malignancies with PET\/CT. J Nucl Med 2005,46(5),752-757","journal-title":"J Nucl Med"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2214\/AJR.09.3731","volume":"195","author":"Osman M.M.","year":"2010","unstructured":"Osman M.M.; Chaar B.T.; Muzaffar R.; Oliver D.; Reimers H.J.; Walz B.; Nguyen N.C.; 18F-FDG PET\/CT of patients with cancer: comparison of whole-body and limited whole-body technique. AJR Am J Roentgenol 2010,195(6),1397-1403","journal-title":"AJR Am J Roentgenol"},{"key":"ref=51","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/129683","author":"Tasdemir B.","year":"2014","unstructured":"Tasdemir B.; Dostbil Z.; Inal A.; Unal K.; Yildirim S.; Simsek F.S.; Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET\/CT tumor imaging. BioMed Res Int 2014","journal-title":"BioMed Res Int"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1055\/s-0038-1625186","volume":"42","author":"L\u00f6ffler M.","year":"2003","unstructured":"L\u00f6ffler M.; Weckesser M.; Franzius Ch.; Nashan D.; Schober O.; Malignant melanoma and (18)F-FDG-PET: Should the whole body scan include the legs? Nucl Med (Stuttg) 2003,42(4),167-172","journal-title":"Nucl Med (Stuttg)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/MNM.0b013e32833cb8b7","volume":"31","author":"Querellou S.","year":"2010","unstructured":"Querellou S.; Keromnes N.; Abgral R.; Sassolas B.; Le Roux P.Y.; Cavarec M.B.; Le Duc-Pennec A.; Couturier O.; Salaun P.Y.; Clinical and therapeutic impact of 18F-FDG PET\/CT whole-body acquisition including lower limbs in patients with malignant melanoma. Nucl Med Commun 2010,31(9),766-772","journal-title":"Nucl Med Commun"},{"key":"ref=54","first-page":"202","volume":"15","author":"Tan J.C.","year":"2012","unstructured":"Tan J.C.; Chatterton B.E.; Is there an added clinical value of \u201ctrue\u201dwhole body(18)F-FDG PET\/CT imaging in patients with malignant melanoma? Hell J Nucl Med 2012,15(3),202-205","journal-title":"Hell J Nucl Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/MNM.0000000000000747","volume":"38","author":"Plouznikoff N.","year":"2017","unstructured":"Plouznikoff N.; Arsenault F.; Clinical relevance of 18F-FDG PET\/CT lower-limb imaging in patients with malignant cutaneous melanoma. Nucl Med Commun 2017,38(12),1103-1108","journal-title":"Nucl Med Commun"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1097\/RLU.0b013e3182a77cae","volume":"38","author":"Lazaga F.J.","year":"2013","unstructured":"Lazaga F.J.; Oz O.K.; Adams-Huet B.; Anderson J.; Mathews D.; Comparison of whole-body versus limited whole-body 18F-FDG PET\/CT scan in malignant cutaneous melanoma. Clin Nucl Med 2013,38(11),882-884","journal-title":"Clin Nucl Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1097\/MNM.0b013e32827420cc","volume":"28","author":"Niederkohr R.D.","year":"2007","unstructured":"Niederkohr R.D.; Rosenberg J.; Shabo G.; Quon A.; Clinical value of including the head and lower extremities in 18F-FDG PET\/CT imaging for patients with malignant melanoma. Nucl Med Commun 2007,28(9),688-695","journal-title":"Nucl Med Commun"},{"key":"ref=58","first-page":"1","volume":"37","year":"2007","unstructured":"The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007,37(2-4),1-332","journal-title":"Ann ICRP"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.2006.06.6068","volume":"24","author":"Weber W.A.","year":"2006","unstructured":"Weber W.A.; Positron emission tomography as an imaging biomarker. J Clin Oncol 2006,24(20),3282-3291","journal-title":"J Clin Oncol"},{"key":"ref=60","first-page":"901","volume":"74","author":"Larson S.M.","year":"2006","unstructured":"Larson S.M.; Schwartz L.H.; 18F-FDG PET as a candidate for \u201cqualified biomarker\u201d: functional assessment of treatment response in oncology. J Nucl Med 2006,74(6),901-903","journal-title":"J Nucl Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1095-0397(01)00061-9","volume":"4","author":"Thie J.A.","year":"2002","unstructured":"Thie J.A.; Hubner K.F.; Smith G.T.; Optimizing imaging time for improved performance in oncology PET studies. Mol Imaging Biol 2002,4(3),238-244","journal-title":"Mol Imaging Biol"},{"key":"ref=62","first-page":"559","volume":"45","author":"Schoder H.","year":"2004","unstructured":"Schoder H.; Erdi Y.E.; Chao K.; Gonen M.; Larson S.M.; Yeung H.W.; Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients-comparison. J Nucl Med 2004,45(4),559-566","journal-title":"J Nucl Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2967\/jnumed.110.080382","volume":"52","author":"El Fakhri G.","year":"2011","unstructured":"El Fakhri G.; Surti S.; Trott C.M.; Scheuermann J.; Karp J.S.; Improvement in lesion detection with whole-body oncologic time-of-flight PET. J Nucl Med 2011,52(3),347-353","journal-title":"J Nucl Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"e323","DOI":"10.1097\/RLU.0000000000001170","volume":"41","author":"Thompson H.M.","year":"2016","unstructured":"Thompson H.M.; Minamimoto R.; Jamali M.; Barkhodari A.; von Eyben R.; Iagaru A.A.; Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET\/CT Scanners. Clin Nucl Med 2016,41(7),e323-e326","journal-title":"Clin Nucl Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2967\/jnumed.114.148338","volume":"56","author":"Nguyen N.C.","year":"2015","unstructured":"Nguyen N.C.; Vercher-Conejero J.L.; Sattar A.; Miller M.A.; Maniawski P.J.; Jordan D.W.; Muzic R.F.; Su K.H.; O\u2019Donnell J.K.; Faulhaber P.F.; Image Quality and Diagnostic Performance of a Digital PET Prototype in Patients with Oncologic Diseases: Initial Experience and Comparison with Analog PET. J Nucl Med 2015,56(9),1378-1385","journal-title":"J Nucl Med"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"462","DOI":"10.2967\/jnumed.107.044834","volume":"49","author":"Karp J.S.","year":"2008","unstructured":"Karp J.S.; Surti S.; Daube-Witherspoon M.E.; Muehllehner G.; Benefit of time-of-flight in PET: experimental and clinical results. J Nucl Med 2008,49(3),462-470","journal-title":"J Nucl Med"},{"key":"ref=67","first-page":"2383","author":"Degenhardt C.","year":"2009","unstructured":"Degenhardt C.; Prescher G.; Frach T.;  The digital silicon photomultiplier: a novel sensor for the detection of scintillation light 2009,2383-2386","journal-title":"The digital silicon photomultiplier: a novel sensor for the detection of scintillation light"},{"key":"ref=68","first-page":"1959","author":"Frach T.","year":"2009","unstructured":"Frach T.; Prescher G.; Degenhardt C.; de Gruyter R.; Schmitz A.; Ballizany R.;  The digital silicon photomultiplier: principle of operation and intrinsic detector performance 2009,1959-1965","journal-title":"The digital silicon photomultiplier: principle of operation and intrinsic detector performance"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1109\/NSSMIC.2012.6551643","author":"Degenhardt C.","year":"2012","unstructured":"Degenhardt C.; Rodrigues P.; Trindade A.;  Performance evaluation of a prototype positron emission tomography scanner using digital photon counters (DPC) 2012,2820-2824","journal-title":"Performance evaluation of a prototype positron emission tomography scanner using digital photon counters (DPC)"},{"key":"ref=70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178936","volume":"12","author":"Baratto L.","year":"2017","unstructured":"Baratto L.; Park S.Y.; Hatami N.; Davidzon G.; Srinivas S.; Gambhir S.S.; Iagaru A.; 18F-FDG silicon photomultiplier PET\/CT: A pilot study comparing semi-quantitative measurements with standard PET\/CT. PLoS One 2017,12(6)","journal-title":"PLoS One"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.2967\/jnumed.117.189514","volume":"58","author":"Hsu D.F.C.","year":"2017","unstructured":"Hsu D.F.C.; Ilan E.; Peterson W.T.; Uribe J.; Lubberink M.; Levin C.S.; Studies of a Next-Generation Silicon-Photomultiplier-Based Time-of-Flight PET\/CT System. J Nucl Med 2017,58(9),1511-1518","journal-title":"J Nucl Med"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/RLU.0000000000002024","volume":"43","author":"Aljared A.","year":"2018","unstructured":"Aljared A.; Alharbi A.A.; Huellner M.W.; BSREM Reconstruction for Improved Detection of In-Transit Metastases With Digital FDG-PET\/CT in Patients With Malignant Melanoma. Clin Nucl Med 2018,43(5),370-371","journal-title":"Clin Nucl Med"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1245\/s10434-014-4100-0","volume":"22","author":"Read R.L.","year":"2015","unstructured":"Read R.L.; Haydu L.; Saw R.P.; Quinn M.J.; Shannon K.; Spillane A.J.; Stretch J.R.; Scolyer R.A.; Thompson J.F.; In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy. Ann Surg Oncol 2015,22(2),475-481","journal-title":"Ann Surg Oncol"},{"key":"ref=74","doi-asserted-by":"publisher","DOI":"10.1117\/1.JMI.4.1.011013","volume":"4","author":"Jones T.","year":"2017","unstructured":"Jones T.; Townsend D.; History and future technical innovation in positron emission tomography. J Med Imaging (Bellingham) 2017,4(1)","journal-title":"J Med Imaging (Bellingham)"},{"key":"ref=75","first-page":"56","volume":"5","author":"Osborne D.R.","year":"2014","unstructured":"Osborne D.R.; Acuff S.; Cruise S.; Syed M.; Neveu M.; Stuckey A.; Bradley Y.; Quantitative and qualitative comparison of continuous bed motion and traditional step and shoot PET\/CT. Am J Nucl Med Mol Imaging 2014,5(1),56-64","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00259-015-3226-z","volume":"43","author":"Schatka I.","year":"2016","unstructured":"Schatka I.; Weiberg D.; Reichelt S.; Owsianski-Hille N.; Derlin T.; Berding G.; Bengel F.M.; A randomized, double-blind, crossover comparison of novel continuous bed motion versus traditional bed position whole-body PET\/CT imaging. Eur J Nucl Med Mol Imaging 2016,43(4),711-717","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40658-015-0132-1","volume":"2","author":"Rausch I.","year":"2015","unstructured":"Rausch I.; Cal-Gonz\u00e1lez J.; Dapra D.; Gallowitsch H.J.; Lind P.; Beyer T.; Minear G.; Performance evaluation of the Biograph mCT Flow PET\/CT system according to the NEMA NU2-2012 standard. EJNMMI Phys 2015,2(1),26","journal-title":"EJNMMI Phys"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2967\/jnmt.116.172171","volume":"44","author":"Acuff S.N.","year":"2016","unstructured":"Acuff S.N.; Osborne D.; Clinical Workflow Considerations for Implementation of Continuous-Bed-Motion PET\/CT. J Nucl Med Technol 2016,44(2),55-58","journal-title":"J Nucl Med Technol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/1097-0142(20000901)89:5<1019:AID-CNCR11>3.0.CO;2-0","volume":"89","author":"Tyler D.S.","year":"2000","unstructured":"Tyler D.S.; Onaitis M.; Kherani A.; Hata A.; Nicholson E.; Keogan M.; Fisher S.; Coleman E.; Seigler H.F.; Positron emission tomography scanning in malignant melanoma. Cancer 2000,89(5),1019-1025","journal-title":"Cancer"},{"key":"ref=80","first-page":"2628","volume":"56","author":"Acuff S.","year":"2015","unstructured":"Acuff S.; Bradley Y.; Stuckey A.; Osborne D.; PET\/CT gating workflow efficiency improvements using continuous bed motion imaging techniques.[abstract] J Nucl Med 2015,56(Suppl. 3),2628","journal-title":"J Nucl Med"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00003072-200502000-00015","volume":"30","author":"Papathanassiou D.","year":"2005","unstructured":"Papathanassiou D.; Liehn J.C.; Bourgeot B.; Amir R.; Marcus C.; Cesium attenuation correction of the liver dome revealing hepatic lesion missed with computed tomography attenuation correction because of the respiratory motion artifact. Clin Nucl Med 2005,30(2),120-121","journal-title":"Clin Nucl Med"},{"key":"ref=82","first-page":"876","volume":"43","author":"Nehmeh S.A.","year":"2002","unstructured":"Nehmeh S.A.; Erdi Y.E.; Ling C.C.; Rosenzweig K.E.; Schoder H.; Larson S.M.; Macapinlac H.A.; Squire O.D.; Humm J.L.; Effect of respiratory gating on quantifying PET images of lung cancer. J Nucl Med 2002,43(7),876-881","journal-title":"J Nucl Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12149-010-0442-2","volume":"25","author":"Kawano T.","year":"2011","unstructured":"Kawano T.; Ohtake E.; Inoue T.; Deep-inspiration breath-hold PET\/CT versus free breathing PET\/CT and respiratory gating PET for reference: evaluation in 95 patients with lung cancer. Ann Nucl Med 2011,25(2),109-116","journal-title":"Ann Nucl Med"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2214\/AJR.09.2516","volume":"193","author":"Werner M.K.","year":"2009","unstructured":"Werner M.K.; Parker J.A.; Kolodny G.M.; English J.R.; Palmer M.R.; Respiratory gating enhances imaging of pulmonary nodules and measurement of tracer uptake in FDG PET\/CT. AJR Am J Roentgenol 2009,193(6),1640-1645","journal-title":"AJR Am J Roentgenol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/MNM.0000000000000048","volume":"35","author":"P\u00e9pin A.","year":"2014","unstructured":"P\u00e9pin A.; Daouk J.; Bailly P.; Hapdey S.; Meyer M.E.; Management of respiratory motion in PET\/computed tomography: the state of the art. Nucl Med Commun 2014,35(2),113-122","journal-title":"Nucl Med Commun"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"712","DOI":"10.2967\/jnumed.106.038034","volume":"48","author":"Meirelles G.S.","year":"2007","unstructured":"Meirelles G.S.; Erdi Y.E.; Nehmeh S.A.; Squire O.D.; Larson S.M.; Humm J.L.; Sch\u00f6der H.; Deep-inspiration breath-hold PET\/CT: clinical findings with a new technique for detection and characterization of thoracic lesions. J Nucl Med 2007,48(5),712-719","journal-title":"J Nucl Med"},{"key":"ref=87","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005882","volume":"96","author":"B\u00e4rwolf R.","year":"2017","unstructured":"B\u00e4rwolf R.; Zirnsak M.; Freesmeyer M.; Breath-hold and free-breathing F-18-FDG-PET\/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters. Medicine (Baltimore) 2017,96(2)","journal-title":"Medicine (Baltimore)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","volume":"32","author":"Nakai T.","year":"2005","unstructured":"Nakai T.; Okuyama C.; Kubota T.; Yamada K.; Ushijima Y.; Taniike K.; Suzuki T.; Nishimura T.; Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging 2005,32(11),1253-1258","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=89","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-68517-5","author":"Iagaru A.","year":"2018","unstructured":"Iagaru A.; Hope T.; Veit-Haibach P.;  PET\/MRI in Oncology 2018","journal-title":"PET\/MRI in Oncology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejca.2005.10.008","volume":"42","author":"M\u00fcller-Horvat C.","year":"2006","unstructured":"M\u00fcller-Horvat C.; Radny P.; Eigentler T.K.; Sch\u00e4fer J.; Pfannenberg C.; Horger M.; Khorchidi S.; N\u00e4gele T.; Garbe C.; Claussen C.D.; Schlemmer H.P.; Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 2006,42(3),342-350","journal-title":"Eur J Cancer"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","volume":"43","author":"Pfannenberg C.","year":"2007","unstructured":"Pfannenberg C.; Aschoff P.; Schanz S.; Eschmann S.M.; Plathow C.; Eigentler T.K.; Garbe C.; Brechtel K.; Vonthein R.; Bares R.; Claussen C.D.; Schlemmer H.P.; Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007,43(3),557-564","journal-title":"Eur J Cancer"},{"key":"ref=92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137285","volume":"10","author":"Beiderwellen K.","year":"2015","unstructured":"Beiderwellen K.; Geraldo L.; Ruhlmann V.; Heusch P.; Gomez B.; Nensa F.; Umutlu L.; Lauenstein T.C.; Accuracy of [18F]FDG PET\/MRI for the Detection of Liver Metastases. PLoS One 2015,10(9)","journal-title":"PLoS One"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ejrad.2009.04.059","volume":"75","author":"Laurent V.","year":"2010","unstructured":"Laurent V.; Trausch G.; Bruot O.; Olivier P.; Felblinger J.; R\u00e9gent D.; Comparative study of two whole-body imaging techniques in the case of melanoma metastases: advantages of multi-contrast MRI examination including a diffusion-weighted sequence in comparison with PET-CT. Eur J Radiol 2010,75(3),376-383","journal-title":"Eur J Radiol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1007\/s00259-018-4061-9","volume":"45","author":"Schaarschmidt B.M.","year":"2018","unstructured":"Schaarschmidt B.M.; Grueneisen J.; Stebner V.; Klode J.; Stoffels I.; Umutlu L.; Schadendorf D.; Heusch P.; Antoch G.; P\u00f6ppel T.D.; Can integrated 18F-FDG PET\/MR replace sentinel lymph node resection in malignant melanoma? Eur J Nucl Med Mol Imaging 2018,45(12),2093-2102","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-017-3813-2","volume":"45","author":"Seith F.","year":"2018","unstructured":"Seith F.; Forschner A.; Schmidt H.; Pfannenberg C.; G\u00fcckel B.; Nikolaou K.; la Foug\u00e8re C.; Garbe C.; Schwenzer N.; 18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start. Eur J Nucl Med Mol Imaging 2018,45(1),95-101","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1148\/radiol.2015150489","volume":"278","author":"Burris N.S.","year":"2016","unstructured":"Burris N.S.; Johnson K.M.; Larson P.E.; Hope M.D.; Nagle S.K.; Behr S.C.; Hope T.A.; Detection of Small Pulmonary Nodules with Ultrashort Echo Time Sequences in Oncology Patients by Using a PET\/MR System. Radiology 2016,278(1),239-246","journal-title":"Radiology"}],"container-title":["Current Radiopharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/175666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,28]],"date-time":"2020-03-28T08:24:06Z","timestamp":1585383846000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/175666\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,13]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3,13]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1874471012666191015095550","relation":{},"ISSN":["1874-4710"],"issn-type":[{"value":"1874-4710","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,13]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}